https://www.openbell.ai/ 2026-10-19T18:38:16.922Z hourly 1.0 https://www.openbell.ai/support 2026-10-19T18:38:16.922Z monthly 0.7 https://www.openbell.ai/privacy 2026-10-19T18:38:16.922Z monthly 0.5 https://www.openbell.ai/terms 2026-10-19T18:38:16.922Z monthly 0.5 https://www.openbell.ai/feed.json 2026-10-19T18:38:16.922Z hourly 0.8 https://www.openbell.ai/news/BIVI:1792435077529 2026-10-19T18:37:57.529Z daily 0.9 https://cdn.brandfetch.io/BIVI/w/400/h/400?c=1idopYfmtR7ZKg8QMud BioVie shares are trading higher after the company announced the presentation of Phase 2 Long COVID data showing statistically significant improvements in fatigue and cognitive measures in certain patient subgroups treated with bezisterim. openbell Financial News https://www.openbell.ai/news/YHC:1792434824240 2026-10-19T18:33:44.240Z daily 0.9 https://cdn.brandfetch.io/YHC/w/400/h/400?c=1idopYfmtR7ZKg8QMud LQR House shares are trading higher after the company announced a one-year agreement to secure up to $3 million in OpenAI-powered AI computing resources for AI research and portfolio optimization initiatives. openbell Financial News https://www.openbell.ai/news/POM:1792434405049 2026-10-19T18:26:45.049Z daily 0.9 https://cdn.brandfetch.io/POM/w/400/h/400?c=1idopYfmtR7ZKg8QMud POMDOCTOR shares are trading higher after the company announced plans to terminate its ADR program and directly list its Class A ordinary shares on the Nasdaq. openbell Financial News https://www.openbell.ai/news/XHB:1792433581148 2026-10-19T18:13:01.148Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/19/homebuilders-ai2.png?width=250&height=187 Homebuilder Sentiment Hits 2012 Lows As Stocks Trade Like They Did During COVID-19 Pandemic The NAHB/Wells Fargo Housing Market Index (HMI) fell to 29 in October, marking the lowest level since June 2012 and below economists' expectations of 32. Key components of the index, including current sales conditions and prospective buyer traffic, also declined significantly. Builders are responding to decreased demand by cutting prices, with 43% reporting price reductions averaging 6%, while 65% are offering sales incentives. The average 30-year fixed mortgage rate reached 7.40%, contributing to weakened buyer confidence and a forecasted decline in housing activity until late 2027. https://www.openbell.ai/news/GSK:1792433284153 2026-10-19T18:08:04.153Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/19/Rueil-malmaison--France---August-13--202.jpg?width=250&height=187 FDA Clears GSK Drug That Could Change How Certain Rectal Cancers Are Treated The FDA has granted accelerated approval to GSK plc for Jemperli (dostarlimab-gxly), the first immunotherapy for adults with stage II and III mismatch repair deficient (dMMR) or microsatellite instability-high (MSI-H) locally advanced rectal cancer. This approval allows eligible patients to avoid traditional treatments that can lead to severe complications. In the AZUR-1 Phase II clinical trial, nearly 75% of participants avoided surgery, chemotherapy, and radiotherapy, with 68% achieving a complete clinical response at the 12-month mark. Following the announcement, GSK shares rose 0.32% to $49.67. https://www.openbell.ai/news/GILD:1792433228699 2026-10-19T18:07:08.699Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/19/Close-Up-Of-Gilead-Sciences-Logo-And-Sig.jpg?width=250&height=187 Gilead Bolsters Inflammatory Bowel Disease Pipeline With Promising Mid-Stage Trial Success Gilead Sciences Inc. (NASDAQ: GILD) announced positive results from its Phase 2 SWIFT trial for emvistegrast, an oral treatment for ulcerative colitis, showing that 66% of patients on the 200 mg dose achieved a clinical response at 12 weeks, compared to 37% in the placebo group. The trial also indicated significant improvements in secondary endpoints, including clinical remission and endoscopic improvement. Gilead plans to continue the SWIFT study to evaluate long-term maintenance outcomes. At the time of publication, Gilead's stock was down 0.75% to $155.02. https://www.openbell.ai/news/MU:1792433078517 2026-10-19T18:04:38.517Z daily 0.9 https://cdn.brandfetch.io/MU/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of memory- and storage-related chip companies are trading higher amid a broader chip rebound. Concerns over AI cloud services providers' debt levels may be subsiding, which could place more attention on the high demand and supply bottleneck narratives. openbell Financial News https://www.openbell.ai/news/ORKA:1792432961202 2026-10-19T18:02:41.202Z daily 0.9 https://cdn.brandfetch.io/ORKA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Oruka Therapeutics shares are trading higher after BTIG reiterated its Buy rating on the stock and maintained a $151 price target. openbell Financial News https://www.openbell.ai/news/SYRE:1792432814551 2026-10-19T18:00:14.551Z daily 0.9 https://cdn.brandfetch.io/SYRE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Spyre Therapeutics shares are trading higher after BTIG reiterated its Buy rating on the stock and maintained a $121 price target. openbell Financial News https://www.openbell.ai/news/GUTS:1792432804049 2026-10-19T18:00:04.049Z daily 0.9 https://cdn.brandfetch.io/GUTS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Morgan Stanley Maintains Equal-Weight on Fractyl Health, Lowers Price Target to $4 Morgan Stanley analyst Michael Ulz has maintained an Equal-Weight rating on Fractyl Health (NASDAQ: GUTS) while significantly lowering the price target from $24 to $4. This adjustment reflects a reassessment of the company's market position and potential. https://www.openbell.ai/news/DXC:1792432736565 2026-10-19T17:58:56.565Z daily 0.9 https://cdn.brandfetch.io/DXC/w/400/h/400?c=1idopYfmtR7ZKg8QMud DXC Technology shares are trading higher following reports suggesting that the company is in advanced talks to sell its insurance software and services division to private investment firm Eldridge Industries for about $2.4 billion. openbell Financial News https://www.openbell.ai/news/AMAT:1792432618642 2026-10-19T17:56:58.642Z daily 0.9 https://cdn.brandfetch.io/AMAT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of semiconductor and chip companies are trading higher as the sector rebounds from last week's weakness, with CoreWeave, the bellwether, rising on a Goldman Sachs upgrade. The Philadelphia Semiconductor Index is expected to end its longest losing streak since the 2008 financial crisis. openbell Financial News https://www.openbell.ai/news/RHHBY:1792432388688 2026-10-19T17:53:08.688Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/19/Roche-Logo--Signage-On-The-Facade-Of-Roc.jpg?width=250&height=187 Swiss Pharma Giant Roche Suspends German Capital Commitments Amid Dispute Over Drug Discounts Roche Holdings AG has suspended all future investment decisions in Germany due to government healthcare austerity measures, specifically the GKV Contribution Rate Stabilization Act, which increases mandatory discounts on patent-protected drugs from 7% to 15.5% starting January 2027. The company argues these changes undermine long-term planning and could drive research and production abroad. Roche has invested approximately 3.8 billion euros in Germany since 2020 and employs around 18,600 people there. In contrast, Roche announced a new partnership with Hansoh Pharmaceutical Group in China, involving an upfront payment of $400 million and potential milestone payments exceeding $15 billion. https://www.openbell.ai/news/IRON:1792432271190 2026-10-19T17:51:11.190Z daily 0.9 https://cdn.brandfetch.io/IRON/w/400/h/400?c=1idopYfmtR7ZKg8QMud BMO Capital Maintains Outperform on Disc Medicine, Raises Price Target to $120 BMO Capital analyst Evan David Seigerman has maintained an 'Outperform' rating on Disc Medicine (NASDAQ: IRON) and increased the price target from $100 to $120. This adjustment reflects a positive outlook for the company's performance in the market. https://www.openbell.ai/news/MDXH:1792432228921 2026-10-19T17:50:28.921Z daily 0.9 https://cdn.brandfetch.io/MDXH/w/400/h/400?c=1idopYfmtR7ZKg8QMud MDxHealth shares are trading lower after BTIG downgraded the stock from Buy to Neutral rating. openbell Financial News https://www.openbell.ai/news/SLE:1792432080221 2026-10-19T17:48:00.221Z daily 0.9 https://cdn.brandfetch.io/SLE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Super League Enterprise shares are trading higher after stockholders approved all proposals related to Metaplanet's planned strategic investment, including a contribution of 2,100 Bitcoin and $2.5 million in cash. openbell Financial News https://www.openbell.ai/news/GFL:1792431964956 2026-10-19T17:46:04.956Z daily 0.9 https://cdn.brandfetch.io/GFL/w/400/h/400?c=1idopYfmtR7ZKg8QMud 'Canada’s Hockey-Playing Garbage Billionaire Lures Suitors for His Empire' - Bloomberg Patrick Dovigi, the billionaire founder of GFL Environmental, is reportedly attracting interest from potential buyers for his waste management empire. The company, known for its significant role in the Canadian waste management sector, is nearing a historic deal that could reshape the industry landscape. GFL's strategic positioning and growth in the market have made it a valuable target for acquisition. https://www.openbell.ai/news/BLK:1792431830481 2026-10-19T17:43:50.481Z daily 0.9 https://cdn.brandfetch.io/BLK/w/400/h/400?c=1idopYfmtR7ZKg8QMud BMO Capital Maintains Outperform on BlackRock, Raises Price Target to $1350 BMO Capital analyst James Fotheringham has maintained an 'Outperform' rating on BlackRock (NYSE: BLK) and raised the price target from $1300 to $1350. https://www.openbell.ai/news/CLSK:1792431746010 2026-10-19T17:42:26.010Z daily 0.9 https://cdn.brandfetch.io/CLSK/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of AI cloud services companies are trading higher as the sector rebounds from recent weakness after Goldman Sachs upgraded CoreWeave, easing concerns about AI infrastructure. openbell Financial News https://www.openbell.ai/news/CJMB:1792431651662 2026-10-19T17:40:51.662Z daily 0.9 https://cdn.brandfetch.io/CJMB/w/400/h/400?c=1idopYfmtR7ZKg8QMud Callan JMB shares are trading lower after the company's subsidiary terminated its proposed acquisition of oil and gas assets in North Dakota and Montana, citing insufficient diligence to proceed with the transaction. openbell Financial News https://www.openbell.ai/news/LITE:1792431521778 2026-10-19T17:38:41.778Z daily 0.9 https://cdn.brandfetch.io/LITE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of fiber-optic connectivity companies are trading higher amid a rebound in AI infrastructure related stocks. Also, reports suggest that the global optical fiber market may face a 2026 supply shortage of over 150 million fiber-kilometers, which could underpin demand optimism. openbell Financial News https://www.openbell.ai/news/IREN:1792431474226 2026-10-19T17:37:54.226Z daily 0.9 https://cdn.brandfetch.io/IREN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of AI cloud services companies are trading higher as the sector rebounds from recent weakness after Goldman Sachs upgraded CoreWeave, easing concerns about AI infrastructure. openbell Financial News https://www.openbell.ai/news/NI:1792431062758 2026-10-19T17:31:02.758Z daily 0.9 https://cdn.brandfetch.io/NI/w/400/h/400?c=1idopYfmtR7ZKg8QMud BMO Capital Maintains Outperform on NiSource, Raises Price Target to $48 BMO Capital analyst James Thalacker has maintained an Outperform rating on NiSource (NYSE: NI) and increased the price target from $45 to $48. This adjustment reflects a positive outlook for the company in the market. https://www.openbell.ai/news/ASTS:1792430919975 2026-10-19T17:28:39.975Z daily 0.9 https://cdn.brandfetch.io/ASTS/w/400/h/400?c=1idopYfmtR7ZKg8QMud AST SpaceMobile shares are trading higher after the company announced its mobile network operator partners Deutsche Telekom, Orange, Telefónica, and Vodafone signed a letter of intent to explore a potential joint bid for MSS spectrum in Europe. openbell Financial News https://www.openbell.ai/news/CMS:1792430852788 2026-10-19T17:27:32.788Z daily 0.9 https://cdn.brandfetch.io/CMS/w/400/h/400?c=1idopYfmtR7ZKg8QMud BMO Capital Maintains Outperform on CMS Energy, Raises Price Target to $76 BMO Capital analyst James Thalacker has maintained an Outperform rating on CMS Energy (NYSE: CMS) and raised the price target from $73 to $76. This adjustment reflects a positive outlook for the company in the market. https://www.openbell.ai/news/VOYG:1792430603091 2026-10-19T17:23:23.091Z daily 0.9 https://cdn.brandfetch.io/VOYG/w/400/h/400?c=1idopYfmtR7ZKg8QMud Morgan Stanley Maintains Underweight on Voyager Technologies, Lowers Price Target to $36 Morgan Stanley analyst Kristine Liwag has maintained an Underweight rating on Voyager Technologies (NYSE: VOYG) and has reduced the price target from $37 to $36. https://www.openbell.ai/news/TEAM:1792430593315 2026-10-19T17:23:13.315Z daily 0.9 https://cdn.brandfetch.io/TEAM/w/400/h/400?c=1idopYfmtR7ZKg8QMud Atlassian shares are trading higher after Guggenheim maintained its Buy rating on the stock and raised its price target from $165 to $280. Also, Keybanc maintained its Overweight rating and raised its price target from $185 to $235. openbell Financial News https://www.openbell.ai/news/VSXY:1792430550091 2026-10-19T17:22:30.091Z daily 0.9 https://cdn.brandfetch.io/VSXY/w/400/h/400?c=1idopYfmtR7ZKg8QMud Morgan Stanley Maintains Overweight on Victoria's Secret, Raises Price Target to $104 Morgan Stanley analyst Alex Straton has maintained an Overweight rating on Victoria's Secret (NYSE: VSXY) and raised the price target from $101 to $104. This adjustment reflects a positive outlook for the company's stock performance. https://www.openbell.ai/news/WMT:1792430233750 2026-10-19T17:17:13.750Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/19/Walmart-Issues-Urgent-Recall-Warning-For.jpg?width=250&height=187 Analyst Sees Billions in Walmart's Next Big Advertising Opportunity Walmart Inc. (NYSE: WMT) is expected to unlock billions in advertising revenue as it expands its digital advertising business and integrates AI into shopping, according to Bank of America analyst Christopher Nardone, who maintains a Buy rating with a $126 price target. The retailer's access to 150 million weekly shoppers and the addition of third-party marketplace sellers are key factors driving advertising growth. Walmart's acquisitions of Vizio and Vibe.co are also anticipated to create multibillion-dollar opportunities in connected TV advertising. However, potential risks include slowing food inflation and increased competition. https://www.openbell.ai/news/EYPT:1792430199372 2026-10-19T17:16:39.372Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/19/Eye-In-Close-Up-With-Light-Blue-Iris-Det.jpg?width=250&height=187 EyePoint Slashing Workforce, Halting Clinical Trials to Pivot Focus EyePoint Inc. (NASDAQ: EYPT) is reducing its workforce by 53% and halting its clinical trials for wet age-related macular degeneration after its LUCIA Phase 3 trial failed to meet primary endpoints. The company will redirect its resources towards developing the DURAVYU treatment for diabetic macular edema, which has shown positive secondary outcomes in previous trials. The workforce reduction is expected to save approximately $30 million annually, although it will incur $9 million in one-time severance costs. Following these announcements, EyePoint's stock price fell 85.46% to $0.43, marking a new 52-week low. https://www.openbell.ai/news/CRMD:1792430121103 2026-10-19T17:15:21.103Z daily 0.9 https://cdn.brandfetch.io/CRMD/w/400/h/400?c=1idopYfmtR7ZKg8QMud Needham Reiterates Buy on Cormedix, Maintains $15 Price Target Needham analyst Serge Belanger has reiterated a Buy rating on Cormedix (NASDAQ: CRMD) and maintained a price target of $15 for the stock. This endorsement reflects confidence in the company's performance and potential for growth. https://www.openbell.ai/news/DKNG:1792430034838 2026-10-19T17:13:54.838Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/19/Spokane--Wausa---June-2020-View-Of-Draft.jpg?width=250&height=187 Why Is DraftKings Stock Surging on Monday? DraftKings Inc. (NASDAQ: DKNG) shares rose 3.28% to $19.52 on Monday, following an increase in price target to $30 by Wells Fargo, which maintained its Overweight rating. The stock is recovering from a 52-week low of $18.35 and is supported by a consensus of 27 analysts who have a Buy rating, with an average price target of $34 indicating a potential upside of 76.4%. Investors are anticipating the company's earnings report on November 5, with expectations of a loss of 36 cents per share and revenue growth to $1.40 billion from $1.14 billion a year earlier. https://www.openbell.ai/news/OCUL:1792429958941 2026-10-19T17:12:38.941Z daily 0.9 https://cdn.brandfetch.io/OCUL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Needham Reiterates Buy on Ocular Therapeutix, Maintains $18 Price Target Needham analyst Serge Belanger has reiterated a Buy rating on Ocular Therapeutix (NASDAQ: OCUL) and maintained a price target of $18 for the company's stock. https://www.openbell.ai/news/MGM:1792429808795 2026-10-19T17:10:08.795Z daily 0.9 https://cdn.brandfetch.io/MGM/w/400/h/400?c=1idopYfmtR7ZKg8QMud Morgan Stanley Maintains Underweight on MGM Resorts International, Lowers Price Target to $29 Morgan Stanley analyst Stephen Grambling has maintained an Underweight rating on MGM Resorts International (NYSE: MGM) and has reduced the price target from $43 to $29. https://www.openbell.ai/news/SYRE:1792429771374 2026-10-19T17:09:31.374Z daily 0.9 https://cdn.brandfetch.io/SYRE/w/400/h/400?c=1idopYfmtR7ZKg8QMud BTIG Reiterates Buy on Spyre Therapeutics, Maintains $121 Price Target BTIG analyst Julian Harrison has reiterated a 'Buy' rating on Spyre Therapeutics (NASDAQ: SYRE) and has maintained a price target of $121 for the stock. This endorsement suggests confidence in the company's future performance. https://www.openbell.ai/news/META:1792429731126 2026-10-19T17:08:51.126Z daily 0.9 https://cdn.brandfetch.io/META/w/400/h/400?c=1idopYfmtR7ZKg8QMud Morgan Stanley Maintains Overweight on Meta Platforms, Raises Price Target to $820 Morgan Stanley analyst Brian Nowak has maintained an Overweight rating on Meta Platforms (NASDAQ: META) and increased the price target from $775 to $820. This adjustment reflects positive expectations for the company's performance. https://www.openbell.ai/news/DXC:1792429714217 2026-10-19T17:08:34.217Z daily 0.9 https://cdn.brandfetch.io/DXC/w/400/h/400?c=1idopYfmtR7ZKg8QMud 'DXC in advanced talks to sell insurance software unit for $2.4 billion, sources say' - Reuters DXC Technology is reportedly in advanced discussions to sell its insurance software unit for approximately $2.4 billion. This potential sale reflects the company's strategic focus on streamlining operations and enhancing its core business. The transaction could significantly impact DXC's financial position and market strategy. https://www.openbell.ai/news/NXST:1792429668267 2026-10-19T17:07:48.267Z daily 0.9 https://cdn.brandfetch.io/NXST/w/400/h/400?c=1idopYfmtR7ZKg8QMud 'Nexstar asks FCC to reject stay of national TV ownership cap repeal' - TheDesk.net Nexstar Media Group has requested the Federal Communications Commission (FCC) to reject a stay on the repeal of the national television ownership cap. This move is part of Nexstar's strategy to expand its media operations and consolidate its market presence. The outcome of this request could significantly impact the company's growth and competitive positioning in the broadcasting industry. https://www.openbell.ai/news/XHG:1792429550025 2026-10-19T17:05:50.025Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_2.jpg?width=250&height=187 12 Financials Stocks Moving In Monday's Intraday Session On Monday, XChange Tec (NASDAQ:XHG) shares surged 37.0% to $2.74, with a market cap of $87.1 million. Atlantic American (NASDAQ:AAME) also saw a significant increase of 36.3% to $1.43, following the release of its Q4 earnings, and has a market cap of $21.6 million. Conversely, SHF Hldgs (NASDAQ:SHFS) experienced the largest decline, falling 34.1% to $0.09. Other notable losers included House of Doge (NASDAQ:HODO), which dropped 24.47% to $0.07, and Zhibao Technology (NASDAQ:ZBAO), down 20.03% to $0.51. https://www.openbell.ai/news/SLN:1792429549743 2026-10-19T17:05:49.743Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_2.jpg?width=250&height=187 12 Health Care Stocks Moving In Monday's Intraday Session Silence Therapeutics (NASDAQ: SLN) saw a significant stock increase of 125.6% to $19.59, with a market value of $581.1 million. Other notable gainers included SCWorx (NASDAQ: WORX) up 80.32% to $2.49, and Disc Medicine (NASDAQ: IRON) up 40.01% to $79.58, with a market cap of $2.1 billion. Conversely, EyePoint (NASDAQ: EYPT) experienced a sharp decline of 85.7% to $0.43, while Matinas BioPharma Holdings (AMEX: MTNB) fell 33.34% to $1.58. https://www.openbell.ai/news/EXYN:1792429549390 2026-10-19T17:05:49.390Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_4.jpg?width=250&height=187 12 Industrials Stocks Moving In Monday's Intraday Session During Monday's trading session, Exyn Technologies (NASDAQ: EXYN) saw its shares rise by 22.2% to $2.40, with a market capitalization of $15.9 million. Other notable gainers included Amaero (NASDAQ: AMRO), which increased by 16.88% to $5.26, and CDT Environmental Tech (NASDAQ: CDTG), which rose 15.04% to $1.19. Conversely, INLIF (NASDAQ: INLF) experienced a significant decline of 87.5%, dropping to $0.32, with a market cap of $2.8 million. https://www.openbell.ai/news/FUFU:1792429549149 2026-10-19T17:05:49.149Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_2.jpg?width=250&height=187 12 Information Technology Stocks Moving In Monday's Intraday Session On Monday, BitFuFu (NASDAQ:FUFU) saw a significant stock increase of 37.8%, reaching $1.24, with a market capitalization of $218.3 million. Other notable gainers included Bitzero Holdings (NASDAQ:AIBZ) with a 27.89% rise to $2.98 and 3 E Network (NASDAQ:MASK) up 24.48% to $1.0. Conversely, Sangrix (NASDAQ:SGRX) experienced a sharp decline of 40.0%, dropping to $0.52, while Amplitech Group, Inc. - Series B Right (NASDAQ:AMPGZ) fell by 31.11% to $0.07. https://www.openbell.ai/news/FDXF:1792429494710 2026-10-19T17:04:54.710Z daily 0.9 https://cdn.brandfetch.io/FDXF/w/400/h/400?c=1idopYfmtR7ZKg8QMud FedEx Freight Holding shares are trading lower after Stifel lowered its price target on the stock from $160 to $129. openbell Financial News https://www.openbell.ai/news/SLN:1792429369060 2026-10-19T17:02:49.060Z daily 0.9 https://cdn.brandfetch.io/SLN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Why Is Silence Therapeutics Stock Skyrocketing Monday? Silence Therapeutics plc (NASDAQ: SLN) announced its acquisition by Merck KGaA for approximately $1.3 billion in cash, leading to a nearly 126% surge in its stock price to $19.58. The deal, which offers $20 per American depositary share (ADS), represents a 130% premium over Silence's closing price prior to the announcement. The acquisition is expected to close in early 2027, subject to regulatory approvals, and will enhance Merck KGaA's portfolio in rare diseases, particularly through Silence's experimental drug, divesiran. https://www.openbell.ai/news/SLN:1792429362274 2026-10-19T17:02:42.274Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/19/Merger-And-Acquisition-Business-Corporat.jpg?width=250&height=187 Why Is Silence Therapeutics Stock Skyrocketing Monday? Silence Therapeutics plc (NASDAQ: SLN) announced a $1.3 billion acquisition by Merck KGaA, which will pay $20 per American depositary share, representing a 130% premium over Silence's closing price prior to the announcement. Following the news, Silence's stock surged nearly 126%, reaching a new 52-week high with trading volume spiking to 57.883 million shares. The deal, expected to close in early 2027, will enhance Merck KGaA's rare disease pipeline, particularly through Silence's experimental drug divesiran, which targets polycythemia vera. https://www.openbell.ai/news/LYV:1792429333702 2026-10-19T17:02:13.702Z daily 0.9 https://cdn.brandfetch.io/LYV/w/400/h/400?c=1idopYfmtR7ZKg8QMud Morgan Stanley Maintains Overweight on Live Nation Entertainment, Raises Price Target to $215 Morgan Stanley analyst Cameron Mansson-Perrone has maintained an Overweight rating on Live Nation Entertainment (NYSE: LYV) and increased the price target from $200 to $215. This adjustment reflects positive expectations for the company's performance in the market. https://www.openbell.ai/news/ARQT:1792429332901 2026-10-19T17:02:12.901Z daily 0.9 https://cdn.brandfetch.io/ARQT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Arcutis Biotherapeutics shares are trading higher after Guggenheim raised its price target on the stock from $38 to $44. openbell Financial News https://www.openbell.ai/news/SLN:1792429283580 2026-10-19T17:01:23.580Z daily 0.9 https://cdn.brandfetch.io/SLN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Why Is Silence Therapeutics Stock Skyrocketing Monday? Silence Therapeutics plc (NASDAQ: SLN) announced an acquisition by Merck KGaA for approximately $1.3 billion in cash, leading to a nearly 126% surge in its stock price to $19.58. The deal offers $20 per American depositary share, representing a 130% premium over its previous closing price. The acquisition will enhance Merck KGaA's rare disease pipeline, particularly through Silence's divesiran drug, which targets polycythemia vera. The transaction is expected to close in early 2027, pending regulatory approvals. https://www.openbell.ai/news/SLN:1792429223020 2026-10-19T17:00:23.020Z daily 0.9 https://cdn.brandfetch.io/SLN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Why Is Silence Therapeutics Stock Skyrocketing Monday? Silence Therapeutics plc (NASDAQ: SLN) announced a $1.3 billion acquisition by Merck KGaA, which will pay $20 per American depositary share, representing a 130% premium over Silence's closing price prior to the announcement. Following the news, Silence's stock surged nearly 126%, with trading volume reaching 57.883 million shares, significantly higher than its 100-day average of 1.187 million shares. The deal is expected to close in early 2027, pending regulatory and shareholder approvals, and will enhance Merck KGaA's portfolio in rare diseases, particularly through Silence's experimental drug, divesiran. https://www.openbell.ai/news/ASTS:1792429210576 2026-10-19T17:00:10.576Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/19/Los-Angeles--California---July-8-2025-As.jpg?width=250&height=187 AST SpaceMobile Targets 500 Million Subscribers Through European Carrier Partnership AST SpaceMobile, Inc. (NASDAQ: ASTS) has entered a letter of intent with major European carriers including Deutsche Telekom, Orange, Telefónica, and Vodafone Group to explore a joint bid for European Mobile Satellite Services spectrum, aiming to enhance connectivity for over 500 million subscribers. The company's technology, which connects directly to standard smartphones, has demonstrated download speeds of up to 98.9 Mbps, with future models expected to reach nearly 200 Mbps. Following this announcement, ASTS shares rose by 6.86% to $43.45, while the company anticipates a revenue increase to $46.30 million for its upcoming earnings report on November 9, 2026, compared to $14.74 million year-over-year.